Global CRO PPD has opened a central laboratory in Shanghai, China, to deliver global scientific and technical lab expertise to meet growing client demand for these services in China. The new facility, which has been established in association with Shanghai Clinical Research Center (SCRC), will provide high-quality data across a range of technologies and applications for all phases of pharmaceutical development.
The central lab service offering includes safety and general lab testing, specialized testing, biomarker testing and custom assay development and testing services. This new operation provides the same services as PPD’s central labs in Brussels, Belgium; Highland Heights, Kentucky; and Singapore. All of PPD’s central labs use identical testing platforms, calibrators and reagents for all laboratory assays. In addition, the same lot numbers of standards for calibration are used across all labs, ensuring identical results regardless of where testing is performed.
The Shanghai laboratory is accredited via SCRC’s medical license issued by China’s Ministry of Health, as well as the College of American Pathologists, NGSP and ISO 15189 certifications—all of which are crucial to conducting clinical trials in China successfully.
PPD Laboratories also includes good manufacturing practices (GMP) labs in Ireland and Wisconsin, bioanalytical labs in Wisconsin and Virginia and vaccine sciences labs in Virginia and Pennsylvania.